Skip to main content


Placeholder slot

This page contains brief information about avelumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Avelumab is approved to treat:

These uses are approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that avelumab provides a clinical benefit in these patients.

Avelumab is also being studied in the treatment of other types of cancer.

More About Avelumab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Avelumab - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Therapy–Immunotherapy Combinations Effective for Advanced Kidney Cancer

Pembrolizumab Now Second Immunotherapy Approved to Treat Merkel Cell Carcinoma

Targeted Cancer Therapies

FDA Approves Three Immunotherapy Drugs for Patients with Bladder Cancer

Avelumab Becomes First Approved Treatment for Patients with Merkel Cell Carcinoma

Avelumab Induces Sustained Tumor Responses in Some Patients with Rare Skin Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Avelumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: